Search tool

Displaying 91 - 100 of 998

EMCDDA Director at German Bundestag hearing on new psychoactive substances

EMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is...

mdmb-chimica cover

EMCDDA–Europol Joint Report on MDMB-CHMICA

In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment. The two organisations concluded that sufficient...

publication thumbnail

Annual accounts 2015

These are the EMCDDA's final annual accounts for the financial year 2015.

ENP group photo

EMCDDA conference takes stock of project with ENP partner countries

The EU drugs agency (EMCDDA) is hosting a conference in Lisbon today marking the end of a 30-month technical cooperation project within the framework of the European Neighbourhood Policy (ENP).

Publication cover

Drugnet Europe 95

In this issue: European Drug Report 2016 highlights | Return of MDMA | Rises in overdose deaths | Health responses to new psychoactive substances | Gold medal for EMCDDA | World hepatitis...

esdss poster

Fifth European drugs summer school opens today in Lisbon

The fifth European drugs summer school — ‘Illicit drugs in Europe: demand, supply and public policies’ — opened today in Lisbon and will run until 8 July. The initiative, organised by ISCTE...

EMCDDA publishes its first report on health responses to new psychoactive substances

In its latest report, released today ahead of International day against drug abuse and illicit trafficking (26 June), the EMCDDA presents its first analysis of the health responses to NPS.

nps publication cover

Health responses to new psychoactive substances

While prevalence levels of NPS use remain low in the general European population, there are important concerns with more problematic forms of use and harms. This short report provides an overview of...

Publication thumbnail

Health responses to new psychoactive substances (Perspectives on Drugs)

The emergence of new psychoactive substances (NPS) over the last decade has posed a major challenge to drug policy. While the limited available data indicates that prevalence levels of NPS use are...

GRA 2015 cover

General Report of Activities 2015 — Key achievements and governance: a year in review

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...